FloBio Gets FDA Breakthrough Device Designation for Bleeding Risk Diagnostic Test
FloBio announced that the U.S. FDA has granted Breakthrough Device Designation for its rapid bleeding risk diagnostic test.
Read MorePosted by Andy Lundin | Oct 17, 2023 | Hematology & Serology |
FloBio announced that the U.S. FDA has granted Breakthrough Device Designation for its rapid bleeding risk diagnostic test.
Read MorePosted by Andy Lundin | Oct 16, 2023 | Immunoassay Reagents & test Kits |
Werfen announced 510(k) clearance of Aptiva Connective Tissue Disease (CTD) Essential reagent by the U.S. Food and Drug Administration (FDA).
Read MorePosted by Andy Lundin | Oct 13, 2023 | Hematology & Serology, Tubes |
Taking less blood for lab tests using “small-volume” tubes reduced the need for almost one blood transfusion for every 10 patients.
Read MorePosted by Chris Wolski | Oct 6, 2023 | Analytical Software Systems |
A study showed that remote digital morphology could be used to provide services remotely without disrupting laboratory workflow.
Read MorePosted by Chris Wolski | Sep 26, 2023 | Sepsis |
Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read More